AQIA (Aquiva Group) Margin of Safety % (DCF FCF Based): N/A (As of Jun. 25, 2026)


What is Aquiva Group Margin of Safety % (DCF FCF Based)?

Margin of Safety % (DCF FCF Based) = (Intrinsic Value: DCF (FCF Based) - Current Price) / Intrinsic Value: DCF (FCF Based).

Note: Discounted FCF model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Aquiva Group's Predictability Rank is Not Rated. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF FCF Based) is not calculated.

AQIA vs LOGQ, MUSS, KLMN: Margin of Safety % (DCF FCF Based) Comparison

For the Software - Application subindustry, Aquiva Group's Margin of Safety % (DCF FCF Based), along with its competitors' market caps and Margin of Safety % (DCF FCF Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Aquiva Group Margin of Safety % (DCF FCF Based) vs Software Industry

For the Software industry and Technology sector, Aquiva Group's Margin of Safety % (DCF FCF Based) distribution charts can be found below:

* The bar in red indicates where Aquiva Group's Margin of Safety % (DCF FCF Based) falls into.


Aquiva Group Business Description

Address No. 3 Bethesda Metro Center, Suite 700, Bethesda, MD, USA, 20814
Aquiva Group Inc is focused on commercializing materials science technologies in both existing and emerging markets. It has licensed a novel HiPNATM (Hydrogel with InterPenetrating Network Anchor) technology, branded as AquiFormTM, which is a versatile material with key properties, making it an attractive platform for various applications. These applications include transdermal patches that release active ingredients for skin care, nutraceuticals, and other healthcare and cosmetics markets. The company operates across three segments: Consumer Health, Wellness, & Cosmetics; Medical Device; and Therapeutics & Transdermal Drug-Delivery Systems (TDS). Additionally, it is building on an established partnership network and capabilities in contract development to expand its services to new areas.